Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ebolacide 1 and 2 = FAIL. The rest they can't even make useful batches to test = FAIL
POT OF WEED MAY EASE THE PAIN WHEN NNVC FILES BANKRUPTCY
Unless maybe they can make a nano medical marijuana product this scam trash is toast.
Say what? NeverCides has one of the foulest stenches of all the biowreck scams I've seen.
Bullshit -- NeverCides isn't on the "cusp" of TOX since NeverCides still doesn't have a clue how to make 3 consecutive, consistent batches. Without that, the only TOX we will ever see will be part of lying PRs trying to pass off single unique batches as samples.
Since NeverCides can't make even 2 copies of 200g batches which renders both of them useless, what good would 10 "copies" do when each and every "copy" will be different?
What bullshit -- the consistentcy problem is something that has plagued many nanomed companies so Seymour should not have been surprised. He chose to downplay it and instead keep everybody focused on batch size, new monthly flavors, and blaming BASI.
For years it was that they have to make so much of the drug because it's so safe. Nonsense. The main issue was and still that they can't make any useful batches because without consistency they're all worthless.
Batch size is already done. The problem is easy batch is a random soup which is worthless.
Hence jumping around from virus of the month to now even candidate of the month.
None of them work in a capacity that is acceptable to the FDA. They can't even begin TOX despite Seymour successfully bullshitting the naive public back in 2014 with his "samples" scheme.
Name one person in the entire universe who ever said a plant can't be built, equipment can't be bought, and staff can't be hired -- all of which are a 30% profit margin to Diwan.
A 100% loss doesn't matter where anybody bought the shares. Losing 100% of value is the same either way.
NNVC is going to lose 100% of its value.
Bank on it.
Unfortunately the SEC consider "extremely overoptimistic" to be fraud if the CEO making the extremely overoptimistic forecasts had no reasonable basis for making them.
The truth is NeverCides still can't make 3 consecutive, consistent batches of useful size and can't enter TOX without them.
Batch size has been a multi-year (decade+ ?) long red herring with Seymour laughing all the way to the bank.
Maybe Seymour could develop Senileicide and be the first human patient.
ZYXI is already profitable. lol
"The" batch for TOX testing huh? The filings say three consecutive and consistent batches.
All that bullshit is great, but the real problem is NeverCides can figure out how to make useful consistent batches.
Selecting a candidate and making 200g of it is great until NNVC makes a second batch which doesn't look like the first batch. Which is the problem for years and years with no evidence NeverCides is any closer to solving this massive roadblock that has plagued other nano companies.
When a biowreck disaster such as NNVC is even entertaining the idea of listen to a water filtration company for help, I would say the scam is running out of steam.
According to the SEC, it is fraud if a CEO makes a forward-looking statement without a "reasonable basis" for making that statement.
Been smart and entertaining to not bet at all.
ROFL!!!!! Nice try. ZYXI's small audit firm was acquired by a very large accounting firm:
http://www.bizjournals.com/denver/news/2016/10/18/denvers-crowe-ghp-horwath-acquired-by-8th-largest.html
Whether it causes as a delay beyond the 90 days they already get (plus a 15 day allowed extension) remains to be seen, but I've seen new accounting firms come on board and complete an audit within 3 weeks.
I personally found it almost as funny the second time as I found it the first time.
The only thing more funny than that pic of Seymour by the way is that he actually chose that pic while being completely oblivious of how awful it looks even for him.
Then again, who knows, maybe it was calculated to make him look innocent. Surely somebody this oblivious-looking wouldn't continue to recruit Joe Sixpack investors when he knows they will lose their entire investment right?
The problem has little to nothing to do with scale. NeverCides can already make inconsistent and non-duplicate batches at scale.
Yeah but they have to pay for the fake award and pay for the right to put the fake award on their website.
Ah yes so now the theory is NeverCides has done so much failing it is running out of ways to fail so success must be on deck.
That makes sense if I try not to think about it.
Barrick Gold owns Placer Dome, a rather huge company at the time of acquisition.
Is Placer Dome into Placer mining?
Personally I think they should spend about $30,000 on lawyers to get a court to validate a tiny $24,000 debt that's barely over 30 days late.
lol
The first time I heard my premise was false was when I stated, correctly, Ebolacide was a miserably failure.
Ah ha, but it was only a "partial" failure because now they know how to attack Ebola better!
I called bullshit. Then, whaddyaknow? Ebolacide2 failed worse than Ebolacide 1.
I've been hearing that same bullshit since $6 per share and every time the premises and conclusion claimed to be false prove to actually be true.
It's not the ingredients that determine the requirement for FDA approval but rather the fact that NeverCides calls it a drug and wants to market it as a drug. Any product claiming to be a drug needs FDA approval. It doesn't matter if the only ingredients are spring water and salt mixed together and put into a topical cream.
Companies may also want FDA approval from a recipe of harmless ingredients in order to charge a higher price often by making it only available by prescription. Proving efficacy with the FDA allows higher prices and health insurance reimbursement which furthers demand.
Why does everything labeled incorrect always prove to correct down the road?
Correct.
NeverCides is kind of like Mexico -- it is proposed it pays a YUGE tariff to go through Theracour. All of the walls or patents were paid for by NeverCides but only Theracour sees any benefits. In both cases, it stops drugs from coming to market which is a good thing since in both cases the drugs are illegal and would never pass a TOX test in their current status.
Now if the shareholders would just revolt and demand to repeal Seymourcare and replace him with something better (I nominate that Dave guy)....
Mexico is going to pay to keep NNVC over $100 and it's going to be YUGE!!!!!
I think he means Seymour spewing inside information would lead his pen pals to suddenly cease buying until the news is public due to legal and ethical reasons.
Yeah okay.
LOL
To add to that, no doubt we've only seen the few cockroaches in the public space but the real nest of deceit still lies hidden and the authorities will bring it to light.
That's typical how these scams work, and Seymour we know is very sloppy. He no doubt left a some really damning evidence. We've seen a hint of it with his prior lawsuit which revealed his profanity-filled scorn for the shareholders and the authorities.
Would it be considered a lie for NeverCides to claim human trials are "scheduled" (Slide 1) when there is no such thing "scheduled" and no legitimate biotechs make forecast guesses on timeframes and call that "scheduled."
Seems, at best, like an attempt to mislead and fool the public especially among those discovering NeverCides for the first time and seeing that slide.
More like the F grade. Doesn't matter what grade since NeverCides can't even make a single useable batch of ANY grade but F.
Forget all that -- show me one legit company that couldn't make a second useful batch consistent with its first batch of drug then claimed they make could new drugs in a matter of weeks when they haven't ever made a first useful batch of drugs yet.